Jp. Palazzo et al., IMMUNOHISTOCHEMICAL LOCALIZATION OF P21(WAF1) (CIP1) IN NORMAL, HYPERPLASTIC, AND NEOPLASTIC UTERINE TISSUES/, Human pathology, 28(1), 1997, pp. 60-66
p21(WAF1/CIP1) is nuclear protein that binds to cyclin-dependent kinas
e complexes (CDKs) and inhibits the activity of multiple kinases. Thes
e CDKs are involved in the regulation of cell cycle progression at sev
eral checkpoints. Iu this study, the authors have analyzed by immunohi
stochemistry the expression of p21(WAF1/CIP1) in normal uterine tissue
s, 12 endometrial hyperplasias, 17 endocervical adenocarcinomas, and 3
1 endometrial adenocarcinomas. In addition, a group of 10 leiomyomas a
nd 10 uterine leiomyosarcomas were also stained. To evaluate cell prol
iferation, the monoclonal antibody Ki-67 was used In all of the availa
ble cases. Terminally differentiated epithelial endocervical and endom
etrial cells showed variable expression of p21(WAF1/CIP1), whereas the
endometrial hyperplasias, and endocervical and endometrial adenocarci
nomas showed decreased expression or were negative. All of the cases o
f cervical squamous dysplasia were positive. Normal smooth muscle cell
s and 50% of leiomyomas mere negative, whereas all leiomyosarcomas sho
wed expression of p21(WAF1/CIP1). These results indicate that p21(WAF1
/CIP1) contributes to differentiation iu normal endometrial and endoce
rvical glands. The decreased expression of p21(WAF1/CIP1) in endometri
al hyperplasias and carcinomas may be important La the process of neop
lastic transformation. The role of certain CDK inhibitors, such as p21
(WAF1/CIP1), is different ent in epithelial and mesenchymal tumorigene
sis in the uterus. Copyright (C) 1997 by W.B. Saunders Company.